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Introduction
• The possibility of a concurrent flu epidemic with the
COVID-19 pandemic in the US raised concerns of
increased burden on the healthcare system.
• Vaccine hesitancy led to only 48.4% of US adults
getting the flu vaccine in 2019-20.1 Reasons and
barriers should be addressed to increase flu
vaccinations.
• The theory of planned behavior (TPB) stipulates
that intention to carry out a behavior relies on the
participant's attitude towards the behavior,
subjective norms, and perceived behavioral control.

Purpose
• The objective of this study was to assess the
intentions of US adults to receive the 2020-2021
influenza vaccine during COVID-19 based on the
Theory of Planned Behavior.

Methods
• This study utilized a cross-survey design,
administered using SurveyMonkey Audience in
September 2020, to a national panel of US adults
aged 18 years and older.
• The survey had 22 items developed by the authors
based on TPB framework.
• Cronbach's alpha was used to assess internal
consistency of construct items, and a regression
model was used with intention as the dependent
variable and attitude, subjective norm, and
perceived behavioral control as the independent
variables. The model was controlled for
demographic variables.

Results
• Three-hundred sixty-four adults (59.1% female,
66.5% white), completed the survey.
• The items for each of the three TPB constructs
demonstrated adequate reliability – 0.833 for
attitude, 0.899 for subjective norms, and 0.785 for
perceived behavioral control.

Table 1: Notable survey results
Past and future intentions to get the flu vaccine
Received flu vaccine last year
56.00%
Already received flu vaccine by date of survey
19.50%
administration
Likely or very likely to get flu vaccine this year
54.30%
Unlikely or very unlikely to get the flu vaccine this year
33.33%
Beliefs about the flu vaccine
Agreed or strongly agreed flu vaccine is beneficial
46.60%
Agreed or strongly agreed that it protects the people
51.80%
around them or their social circle
Previous diagnosis and intention to get the COVID-19 vaccine
Had not been diagnosed with COVID-19
90%
Likely or very likely to get the COVID-19 vaccine
40%
Unlikely to very unlikely to get the COVID-19 vaccine
25.30%
Preferred flu vaccination location
Will most likely get the flu vaccine at a doctor's office
48.90%
Will most likely get the flu vaccine at a community
30.00%
pharmacy
Barriers to flu vaccination
Concerns about adverse effects from the flu vaccine
41%
Fear of needles
22.30%
Inconvenience
17.20%
Likelihood of various stakeholders to influence participants
Family
58.10%
Doctor
42.70%
Pharmacist
22.60%
Pharmacist providing education or contacting the
23.30%
participant would influence their decision to get the flu
vaccine

Table 2: Parameter estimates for the regression
model predicting intention to get the flu vaccine
Attitude
Subjective Norm
Received flu vaccine
last year compared to
no flu vaccine last year
Hispanic compared to
whites
Being a healthcare
provider compared to
not being one

Regression
Coefficient
0.891
0.266
1.445

P-value

-0.726

0.03

-0.542

0.03

0.000
0.005
0.000

Confidence
Intervals
0.714 – 0.168
0.080 – 0.451
1.050 – 1.839
-1.397 –
-0.054
-1.042 –
-0.041

Only significant variables are presented here

Conclusions
• 75% participants had either received or intended to
receive the influenza vaccine this year.
• For those who indicated that they are unlikely to get
the influenza vaccine, doctors and families can play
a significant role in educating patients.
• Limitations include selection and sample bias,
desirability bias where participants may answer
questions positively, and use of a non-validated
questionnaire.
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